Shaping of human germline IgH repertoires revealed by deep sequencing

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 3221-3230

  Larimore, Kevin ^a   McCormick, Michael W ^b   Robins, Harlan S ^c   Greenberg, Philip D ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Adaptive Biotechnologies Corp   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; NEUTRALIZING ANTIBODY;

ARTICLE; B LYMPHOCYTE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DEEP SEQUENCING; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMMUNOGLOBULIN HEAVY CHAIN GENE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; COMPLEMENTARITY DETERMINING REGIONS; COMPUTATIONAL BIOLOGY; CONSERVED SEQUENCE; GENE REARRANGEMENT, B-LYMPHOCYTE; HIV-1; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN JOINING REGION; IMMUNOGLOBULIN VARIABLE REGION; PROTEIN PRECURSORS; SEQUENCE ANALYSIS, DNA; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 84866177970     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201303     Document Type: Article

References (45)

1. Gellert, M. 2002. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71: 101-132. (Pubitemid 34800216)
2. Wilson, I. A., and R. L. Stanfield. 1994. Antibody-antigen interactions: new structures and new conformational changes. Curr. Opin. Struct. Biol. 4: 857-867.
3. Chothia, C., and A. M. Lesk. 1987. Canonical structures for the hypervariable regions of immunoglobulins. J. Mol. Biol. 196: 901-917. (Pubitemid 17127946)
4. Al-Lazikani, B., A. M. Lesk, and C. Chothia. 1997. Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273: 927-948. (Pubitemid 27493729)
5. Morea, V., A. Tramontano, M. Rustici, C. Chothia, and A. M. Lesk. 1998. Conformations of the third hypervariable region in the VH domain of immunoglobulins. J. Mol. Biol. 275: 269-294. (Pubitemid 28030004)
6. Xu, J. L., and M. M. Davis. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13: 37-45.
7. Wardemann, H., S. Yurasov, A. Schaefer, J. W. Young, E. Meffre, and M. C. Nussenzweig. 2003. Predominant autoantibody production by early human B cell precursors. Science 301: 1374-1377. (Pubitemid 37075812)
8. Aguilera, I., J. Melero, A. Nuñez-Roldan, and B. Sanchez. 2001. Molecular structure of eight human autoreactive monoclonal antibodies. Immunology 102: 273-280. (Pubitemid 32281154)
9. Samuels, J., Y.-S. Ng, C. Coupillaud, D. Paget, and E. Meffre. 2005. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 201: 1659-1667. (Pubitemid 40721009)
10. Haynes, B. F., J. Fleming, E. W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R. M. Scearce, K. Plonk, H. F. Staats, et al. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308: 1906-1908. (Pubitemid 40941873)
11. Meffre, E., A. Schaefer, H. Wardemann, P. Wilson, E. Davis, and M. C. Nussenzweig. 2004. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 199: 145-150. (Pubitemid 38076487)
12. Boyd, S. D., E. L. Marshall, J. D. Merker, J. M. Maniar, L. N. Zhang, B. Sahaf, C. D. Jones, B. B. Simen, B. Hanczaruk, K. D. Nguyen, et al. 2009. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med. 1: 12ra23.
13. Koff, W. C. 2012. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem. Vaccine 30: 4310-4315.
14. McElrath, M. J., and B. F. Haynes. 2010. Induction of immunity to human immunodeficiency virus type-1 by vaccination. Immunity 33: 542-554.
15. González, N., A. Alvarez, and J. Alcamí. 2010. Broadly neutralizing antibodies and their significance for HIV-1 vaccines. Curr. HIV Res. 8: 602-612.
16. Xiao, X., W. Chen, Y. Feng, Z. Zhu, P. Prabakaran, Y. Wang, M.-Y. Zhang, N. S. Longo, and D. S. Dimitrov. 2009. Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. Biochem. Biophys. Res. Commun. 390: 404-409.
17. Xiao, X., W. Chen, Y. Feng, and D. S. Dimitrov. 2009. Maturation pathways of cross-reactive HIV-1 neutralizing antibodies. Viruses 1: 802-817.
18. Ma, B.-J., S. M. Alam, E. P. Go, X. Lu, H. Desaire, G. D. Tomaras, C. Bowman, L. L. Sutherland, R. M. Scearce, S. Santra, et al. 2011. Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLoS Pathog. 7: e1002200.
19. Nabel, G. J., P. D. Kwong, and J. R. Mascola. 2011. Progress in the rational design of an AIDS vaccine. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366: 2759-2765.
20. Bonsignori, M., K.-K. Hwang, X. Chen, C.-Y. Tsao, L. Morris, E. Gray, D. J. Marshall, J. A. Crump, S. H. Kapiga, N. E. Sam, et al. 2011. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. J. Virol. 85: 9998-10009.
21. Robins, H. S., P. V. Campregher, S. K. Srivastava, A. Wacher, C. J. Turtle, O. Kahsai, S. R. Riddell, E. H. Warren, and C. S. Carlson. 2009. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114: 4099-4107.
22. Giudicelli, V., D. Chaume, and M.-P. Lefranc. 2005. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 33(Database issue): D256-D261. (Pubitemid 40207873)
23. Robins, H., C. Desmarais, J. Matthis, R. Livingston, J. Andriesen, H. Reijonen, C. Carlson, G. Nepom, C. Yee, and K. Cerosaletti. 2012. Ultra-sensitive detection of rare T cell clones. J. Immunol. Methods 375: 14-19.
24. Robins, H. S., S. K. Srivastava, P. V. Campregher, C. J. Turtle, J. Andriesen, S. R. Riddell, C. S. Carlson, and E. H. Warren. 2010. Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci. Transl. Med. 2: 47ra64.
25. Wesolowski, J., V. Alzogaray, J. Reyelt, M. Unger, K. Juarez, M. Urrutia, A. Cauerhff, W. Danquah, B. Rissiek, F. Scheuplein, et al. 2009. Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. (Berl.) 198: 157-174.
26. Xiang, S.-H., M. Farzan, Z. Si, N. Madani, L. Wang, E. Rosenberg, J. Robinson, and J. Sodroski. 2005. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody. J. Virol. 79: 6068-6077. (Pubitemid 40617212)
27. Ivanov, I. I., R. L. Schelonka, Y. Zhuang, G. L. Gartland, M. Zemlin, and H. W. Schroeder, Jr. 2005. Development of the expressed Ig CDR-H3 repertoire is marked by focusing of constraints in length, amino acid use, and charge that are first established in early B cell progenitors. J. Immunol. 174: 7773-7780. (Pubitemid 40806284)
28. Klonowski, K. D., L. L. Primiano, and M. Monestier. 1999. Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J. Immunol. 162: 1566-1572. (Pubitemid 29307030)
29. Ichiyoshi, Y., and P. Casali. 1994. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J. Exp. Med. 180: 885-895. (Pubitemid 24256601)
30. Meffre, E., M. Milili, C. Blanco-Betancourt, H. Antunes, M. C. Nussenzweig, and C. Schiff. 2001. Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J. Clin. Invest. 108: 879-886. (Pubitemid 32884193)
31. Sanz, I. 1991. Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immunol. 147: 1720-1729.
32. Souto-Carneiro, M. M., N. S. Longo, D. E. Russ, H.-W. Sun, and P. E. Lipsky. 2004. Characterization of the human Ig heavy chain antigen binding complementarity determining region 3 using a newly developed software algorithm, JOINSOLVER. J. Immunol. 172: 6790-6802. (Pubitemid 38669117)
33. Briney, B. S., J. R. Willis, M. D. Hicar, J. W. Thomas, and J. E. Crowe. 2012. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology. In press.
34. Corbett, S. J., I. M. Tomlinson, E. L. Sonnhammer, D. Buck, and G.Winter. 1997. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, "minor" D segments or D-D recombination. J. Mol. Biol. 270: 587-597. (Pubitemid 27313798)
35. Ohm-Laursen, L., M. Nielsen, S. R. Larsen, and T. Barington. 2006. No evidence for the use of DIR, D-D fusions, chromosome 15 open reading frames or VH replacement in the peripheral repertoire was found on application of an improved algorithm, JointML, to 6329 human immunoglobulin H rearrangements. Immunology 119: 265-277. (Pubitemid 44401645)
36. Kyte, J., and R. F. Doolittle. 1982. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 157: 105-132.
37. Alam, S. M., M. McAdams, D. Boren, M. Rak, R. M. Scearce, F. Gao, Z. T. Camacho, D. Gewirth, G. Kelsoe, P. Chen, and B. F. Haynes. 2007. The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J. Immunol. 178: 4424-4435. (Pubitemid 46492394)
38. Zhang, M.-Y., B. K. Vu, A. Choudhary, H. Lu, M. Humbert, H. Ong, M. Alam, R. M. Ruprecht, G. Quinnan, S. Jiang, et al. 2008. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. J. Virol. 82: 6869-6879. (Pubitemid 351977708)
39. Kunert, R., S. Wolbank, G. Stiegler, R. Weik, and H. Katinger. 2004. Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. AIDS Res. Hum. Retroviruses 20: 755-762. (Pubitemid 39037507)
40. Zwick, M. B., H. K. Komori, R. L. Stanfield, S. Church, M. Wang, P. W. H. I. Parren, R. Kunert, H. Katinger, I. A. Wilson, and D. R. Burton. 2004. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. J. Virol. 78: 3155-3161. (Pubitemid 38314375)
41. De Genst, E., K. Silence, K. Decanniere, K. Conrath, R. Loris, J. Kinne, S. Muyldermans, and L. Wyns. 2006. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad. Sci. USA 103: 4586-4591.
42. Raaphorst, F. M., C. S. Raman, J. Tami, M. Fischbach, and I. Sanz. 1997. Human Ig heavy chain CDR3 regions in adult bone marrow pre-B cells display an adult phenotype of diversity: evidence for structural selection of DH amino acid sequences. Int. Immunol. 9: 1503-1515. (Pubitemid 27434682)
43. Wu, X., B. Liu, P. L. Van der Merwe, N. N. Kalis, S. M. Berney, and D. C. Young. 1998. Myosin-reactive autoantibodies in rheumatic carditis and normal fetus. Clin. Immunol. Immunopathol. 87: 184-192. (Pubitemid 28235140)
44. Wu, X., T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N. S. Longo, M. Louder, K. McKee, et al NISC Comparative Sequencing Program. 2011. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 333: 1593-1602.
45. Zwick, M. B., A. F. Labrijn, M. Wang, C. Spenlehauer, E. O. Saphire, J. M. Binley, J. P. Moore, G. Stiegler, H. Katinger, D. R. Burton, and P. W. H. I. Parren. 2001. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75: 10892-10905. (Pubitemid 33034579)